1548 — Genscript Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- HK$27.03bn
- HK$22.73bn
- $959.53m
Annual cashflow statement for Genscript Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -496 | -432 | 169 | -171 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 189 | 68.4 | -496 | 50 | — |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 123 | 179 | -33.9 | 119 | 326 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -137 | -120 | -287 | 75.6 | 326 |
| Capital Expenditures | -137 | -204 | -158 | -148 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -75.2 | -240 | -200 | -1,308 | -172 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -213 | -443 | -358 | -1,456 | -172 |
| Financing Cash Flow Items | -0.194 | -29.7 | -2.24 | 18.2 | -145 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 902 | 419 | 1,068 | 66.5 | -145 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 552 | -157 | 422 | -1,314 | 10.5 |